Published in PLoS One on April 20, 2017
Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J (1996) 16.68
Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev (1998) 12.55
The plasticity of aging: insights from long-lived mutants. Cell (2005) 9.88
Understanding adipocyte differentiation. Physiol Rev (1998) 6.84
Molecular regulation of adipogenesis. Annu Rev Cell Dev Biol (2000) 6.40
Adipogenesis: from stem cell to adipocyte. Annu Rev Biochem (2012) 2.46
Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. Proc Natl Acad Sci U S A (1994) 2.34
Positive and negative regulation of insulin signaling by reactive oxygen and nitrogen species. Physiol Rev (2009) 1.97
Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry (1994) 1.91
Reactive oxygen species facilitate adipocyte differentiation by accelerating mitotic clonal expansion. J Biol Chem (2009) 1.86
Oxygen free radicals and metallothionein. Free Radic Biol Med (1993) 1.84
Insulin receptor synthesis and turnover in differentiating 3T3-L1 preadipocytes. Proc Natl Acad Sci U S A (1980) 1.82
Molecular regulation of adipocyte differentiation. Semin Cell Dev Biol (1999) 1.72
Signaling events for metallothionein induction. Mutat Res (2003) 1.60
Deficiency of metallothionein-1 and -2 genes shortens the lifespan of the 129/Sv mouse strain. Exp Gerontol (2015) 1.43
Obesity and hyperleptinemia in metallothionein (-I and -II) null mice. Proc Natl Acad Sci U S A (1998) 1.32
Recent studies on metallothionein: protection against toxicity of heavy metals and oxygen free radicals. Tohoku J Exp Med (2002) 1.24
Adipocyte dysfunction, inflammation and metabolic syndrome. Rev Endocr Metab Disord (2014) 1.12
Characterisation of six additional human metallothionein genes. Biochim Biophys Acta (1994) 1.07
Redox regulation of FoxO transcription factors. Redox Biol (2015) 1.01
Association of anti-obesity activity of N-acetylcysteine with metallothionein-II down-regulation. Exp Mol Med (2006) 1.00
Polymorphisms in metallothionein-1 and -2 genes associated with the risk of type 2 diabetes mellitus and its complications. Am J Physiol Endocrinol Metab (2008) 0.98
Metallothionein polymorphisms in pathological processes. Metallomics (2014) 0.97
Metallothioneins in brain--the role in physiology and pathology. Toxicol Appl Pharmacol (1997) 0.95
Metallothionein and the biology of aging. Ageing Res Rev (2010) 0.91
Novel -209A/G MT2A polymorphism in old patients with type 2 diabetes and atherosclerosis: relationship with inflammation (IL-6) and zinc. Biogerontology (2005) 0.91
Metallothionein 1G functions as a tumor suppressor in thyroid cancer through modulating the PI3K/Akt signaling pathway. BMC Cancer (2013) 0.89
Metallothionein deletion exacerbates intermittent hypoxia-induced renal injury in mice. Toxicol Lett (2014) 0.89
A high-capacity assay for PPARgamma ligand regulation of endogenous aP2 expression in 3T3-L1 cells. Anal Biochem (2004) 0.86
Development of high-fat-diet-induced obesity in female metallothionein-null mice. FASEB J (2010) 0.86
Regulation of metallothionein gene expression and secretion in rat adipocytes differentiated from preadipocytes in primary culture. Horm Metab Res (2001) 0.85
Metallothioneins: historical review and state of knowledge. Talanta (1998) 0.85
Mechanisms of resveratrol-induced inhibition of clonal expansion and terminal adipogenic differentiation in 3T3-L1 preadipocytes. J Gerontol A Biol Sci Med Sci (2013) 0.84
Link between PI3K/AKT/PTEN Pathway and NOX Proteinin Diseases. Aging Dis (2014) 0.83
Metallothionein prevents intermittent hypoxia-induced cardiac endoplasmic reticulum stress and cell death likely via activation of Akt signaling pathway in mice. Toxicol Lett (2014) 0.83
Transient peaks in zinc and metallothionein levels during differentiation of 3T3L1 cells. Arch Biochem Biophys (1999) 0.83
Regulation of liver zinc metabolism and metallothionein by cAMP, glucagon and glucocorticoids and suppression of free radicals by zinc. Experientia Suppl (1987) 0.82
The Functions of Metallothionein and ZIP and ZnT Transporters: An Overview and Perspective. Int J Mol Sci (2016) 0.81
Metallothionein 2a gene expression is increased in subcutaneous adipose tissue of type 2 diabetic patients. Mol Genet Metab (2012) 0.81
Metallothioneins, ageing and cellular senescence: a future therapeutic target. Curr Pharm Des (2013) 0.81
Antioxidant metallothionein alleviates endoplasmic reticulum stress-induced myocardial apoptosis and contractile dysfunction. Free Radic Res (2015) 0.79
Obesity and metabolomics: metallothioneins protect against high-fat diet-induced consequences in metallothionein knockout mice. OMICS (2015) 0.78
Insulin-sensitive adiposity is associated with a relatively lower risk of diabetes than insulin-resistant adiposity: the Bogalusa Heart Study. Endocrine (2016) 0.78
Obesity and downregulated hypothalamic leptin receptors in male metallothionein-3-null mice. Neurobiol Dis (2011) 0.77
Metallothionein ameliorates burn sepsis partly via activation of Akt signaling pathway in mice: a randomized animal study. World J Emerg Surg (2015) 0.77
Recently discovered adipokines and cardio-metabolic comorbidities in childhood obesity. Int J Mol Sci (2014) 0.76
Metallothioneins 1 and 2, but not 3, are regulated by nutritional status in rat white adipose tissue. Genes Nutr (2016) 0.76
Blockade of metallothioneins 1 and 2 increases skeletal muscle mass and strength. Mol Cell Biol (2016) 0.76
Dual Opposing Roles of Metallothionein Overexpression in C57BL/6J Mouse Pancreatic β-Cells. PLoS One (2015) 0.76